New nonsteroidal anti-inflammatory drug in the treatment of different ocular pathology
Purpose. Evaluation of efficacy and safety of a new nonsteroidal anti-inflammatory drug (NSAID) Broxinac (bromfenac 0.09 %).Patients and methods.The study included 79 patients with different mainly inflammatory eye pathology. All of them have got the instillation of Broxinac 1 per day. The duration...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2016-04-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/295 |